Role of Matra basti in polycystic ovary syndrome: A case report

S. Singh, Kshipra Rajoria, Sachin Sharma, Ashok Regar, R. Jangir, K. Gupta
{"title":"Role of Matra basti in polycystic ovary syndrome: A case report","authors":"S. Singh, Kshipra Rajoria, Sachin Sharma, Ashok Regar, R. Jangir, K. Gupta","doi":"10.4103/jacr.jacr_46_21","DOIUrl":null,"url":null,"abstract":"Polycystic ovary syndrome is a disorder of reproductive women characterized by hyperandrogenism (elevated free testosterone levels and hirsutism), ovulatory dysfunction, and polycystic ovarian morphology. Here, a case of 29-year-old female was presented with complaints of irregular menstrual cycle, only twice during the last six months associated with severe pain in the lower abdomen and back. Acne on the face, facial hair growth, and increase in weight (from 42 kg to 53 kg) were also associated. The diagnosis of Polycystic Ovarian Syndrome (PCOS) was established through Ultrasonography (USG) and blood hormonal profile (prolactin, serum testosterone total, androstenedione value, complete blood count, thyroid profiles, luteinizing hormone, fasting insulin, dehydroepiandrosterone sulfate, follicle-stimulating hormone, sex hormone-binding globulin, progesterone level, and estrogen level). Ayurvedic treatment was planned on the lines of management for Nastaartava (~ceases of menstrual fluid with ovary dysfunction). Matra basti (a form of unctuous enema) was administered in a dose of 75 ml of Phala ghrita regularly for 24 days starting from 6th day of menstruation cycle. The regimen was adopted for two consecutive cycles. Improvement in USG findings showing reduced endometrial thickness from (9 mm to 6 mm) and ovarian size (from 40 mm × 20 mm to 34 mm × 24 mm of right ovary and 39 mm × 18 mm to 36 mm × 22 mm of left ovary), and normal menstrual cycles were noticed after the treatment. The size of follicle also reduced from >12 mm to 3–7 mm in both ovaries. These findings suggest that Ayurvedic management and Matra basti procedures may be beneficial in case of PCOS.","PeriodicalId":239185,"journal":{"name":"Journal of Ayurveda Case Reports","volume":"70 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/jacr.jacr_46_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Polycystic ovary syndrome is a disorder of reproductive women characterized by hyperandrogenism (elevated free testosterone levels and hirsutism), ovulatory dysfunction, and polycystic ovarian morphology. Here, a case of 29-year-old female was presented with complaints of irregular menstrual cycle, only twice during the last six months associated with severe pain in the lower abdomen and back. Acne on the face, facial hair growth, and increase in weight (from 42 kg to 53 kg) were also associated. The diagnosis of Polycystic Ovarian Syndrome (PCOS) was established through Ultrasonography (USG) and blood hormonal profile (prolactin, serum testosterone total, androstenedione value, complete blood count, thyroid profiles, luteinizing hormone, fasting insulin, dehydroepiandrosterone sulfate, follicle-stimulating hormone, sex hormone-binding globulin, progesterone level, and estrogen level). Ayurvedic treatment was planned on the lines of management for Nastaartava (~ceases of menstrual fluid with ovary dysfunction). Matra basti (a form of unctuous enema) was administered in a dose of 75 ml of Phala ghrita regularly for 24 days starting from 6th day of menstruation cycle. The regimen was adopted for two consecutive cycles. Improvement in USG findings showing reduced endometrial thickness from (9 mm to 6 mm) and ovarian size (from 40 mm × 20 mm to 34 mm × 24 mm of right ovary and 39 mm × 18 mm to 36 mm × 22 mm of left ovary), and normal menstrual cycles were noticed after the treatment. The size of follicle also reduced from >12 mm to 3–7 mm in both ovaries. These findings suggest that Ayurvedic management and Matra basti procedures may be beneficial in case of PCOS.
基底基质在多囊卵巢综合征中的作用:1例报告
多囊卵巢综合征是一种以雄激素过多(游离睾酮水平升高和多毛)、排卵功能障碍和多囊卵巢形态为特征的生殖女性疾病。在这里,一个29岁的女性病例提出了月经周期不规则的主诉,在过去的六个月里只有两次伴有严重的下腹和背部疼痛。面部痤疮、面部毛发生长和体重增加(从42公斤增加到53公斤)也有关联。通过超声检查(USG)和血激素(催乳素、血清睾酮总量、雄烯二酮值、全血计数、甲状腺、促黄体生成素、空腹胰岛素、硫酸脱氢表雄酮、促卵泡激素、性激素结合球蛋白、孕酮水平、雌激素水平)对多囊卵巢综合征(PCOS)进行诊断。阿育吠陀治疗计划与Nastaartava(月经液停止伴卵巢功能障碍)的治疗路线一致。从月经周期的第6天开始,定期给药75毫升Phala ghrita(一种润滑灌肠剂)。采用该方案连续两个周期。USG检查结果改善,显示子宫内膜厚度从(9 mm)减少到6 mm,卵巢大小(右卵巢从40 mm × 20 mm减少到34 mm × 24 mm,左卵巢从39 mm × 18 mm减少到36 mm × 22 mm),治疗后月经周期正常。两个卵巢的卵泡大小也从10 ~ 12毫米减少到3 ~ 7毫米。这些发现表明,阿育吠陀治疗和马特拉手术可能对多囊卵巢综合征有益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信